Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Fuel prices in the EU surged by 31.4% in September amid rising energy costs

    October 22, 2026

    Ultrasound Boosts Metal Joint Strength in Russia-China Collaboration

    October 21, 2026

    EU Allocates €3.4 Billion to 77 Projects Advancing Net-Zero Technologies

    October 20, 2026
    Glasgow ArgusGlasgow Argus
    • Home
    • Contact Us
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Glasgow ArgusGlasgow Argus
    Home » Breakthrough in optogenetics earns the 2026 Nobel medicine honor
    Health

    Breakthrough in optogenetics earns the 2026 Nobel medicine honor

    October 6, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    STOCKHOLM, SWEDEN / RankWire.AI / – The field of neuroscience and biological research has been revolutionized by advancements in optogenetics, a technique that allows precise control of nerve cells using light. This innovative approach was recognized with the 2026 Nobel Prize in Physiology or Medicine, awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel. The Nobel Assembly at Karolinska Institutet announced the recipients on October 5. Their pioneering work demonstrated how light-sensitive proteins can regulate nerve-cell activity with remarkable accuracy, opening new pathways for studying how specific brain circuits influence behaviour, memory, and emotion.

    2026 Nobel medicine spotlights optogenetics breakthrough
    2026 Nobel medicine prize recognizes discoveries that established modern optogenetics. (AI-generated image)

    Hegemann and Nagel identified channelrhodopsin, a protein that reacts to light and is found in the single-celled alga Chlamydomonas. When blue light hits the protein, it opens a channel that allows charged ions into the cell, potentially triggering an electrical impulse. They also proved that cells expressing channelrhodopsin could become responsive to light, a crucial step toward using this protein as a biological switch. Their research linked a fundamental biological response to a practical tool adaptable for various cell types.

    Deisseroth extended these findings into neuroscience by inserting the gene encoding channelrhodopsin into rat nerve cells. Using blue light, he was able to activate nerve signals, and he published his groundbreaking results in 2005. Two years later, his experiments demonstrated that this light-controlled switch could function within the brains of living mice. His work helped establish optogenetics as a viable method for controlling neural circuits with exceptional precision, transforming how scientists explore brain function.

    From a protein in algae to a tool for neural research

    Optogenetics merges genetic targeting with light stimulation to activate or inhibit specific cells. Researchers now employ this technique to investigate the roles of distinct nerve-cell groups during particular behaviors or brain activities. According to the Nobel Assembly at Karolinska Institutet, the method has fundamentally altered the way scientists study the living brain. Laboratories around the world utilize optogenetics to map neural circuits associated with movement, learning, memory, emotion, and other vital functions. Additionally, it allows researchers to link cellular changes with observable effects in living organisms.

    The application of optogenetics extends beyond basic research into the realm of neurological and psychiatric disorders. Studies have examined brain pathways involved in conditions such as Parkinson’s disease, epilepsy, depression, and addiction. Clinical trials are also exploring related techniques aimed at restoring vision in individuals with severe visual impairment. While these therapeutic approaches are still in experimental stages, the primary impact of optogenetics remains in its role as a powerful research tool. It continues to be widely used in neuroscience for detailed investigations of specific neural pathways through controlled light stimulation.

    Three scientists share the 2026 Nobel in medicine

    Karl Deisseroth is a faculty member at Stanford University and an investigator with the Howard Hughes Medical Institute in the United States. Hegemann conducts research at Humboldt University of Berlin, while Nagel is affiliated with the University of Würzburg in Germany. These three laureates will split the 12 million Swedish kronor prize. The announcement of the medicine award marked the beginning of the 2026 Nobel series, which continues with honors in physics, chemistry, literature, peace, and economic sciences. Each scientist’s contribution represented a significant milestone in the evolution of modern optogenetics.

    This Nobel recognizes a chain of discoveries that linked fundamental biological research in algae to a widely employed technique in contemporary neuroscience. Channelrhodopsin served as the light-sensitive molecular switch, with subsequent work adapting this switch for precise neural control. Today, optogenetics is utilized across various fields of biology and neuroscience. The laureates will be presented with their Nobel medals and diplomas during the award ceremony in Stockholm on December 10, a date that coincides with the anniversary of Alfred Nobel’s death and the tradition of the Nobel Prize ceremony.

    Related Posts

    New Study Reveals Impact of Environment and Lifestyle on Accelerated Biological Aging

    October 3, 2026

    WHO Releases New Heat Safety Guidance to Mitigate Risks at Large Gatherings

    October 2, 2026

    Natural compound linked to pomegranates shows potential to enhance heart function in HFpEF models

    October 1, 2026

    Health preparedness urged as El Niño escalates globally, warns WMO

    September 24, 2026

    EU Adult Population Shows Over Half Overweight or Obese in 2025, With Obesity Reaching 16.3%

    September 7, 2026

    UN urges faster global action as DRC Ebola outbreak spreads

    September 2, 2026

    Editor's Pick

    Fuel prices in the EU surged by 31.4% in September amid rising energy costs

    October 22, 2026

    Ultrasound Boosts Metal Joint Strength in Russia-China Collaboration

    October 21, 2026

    EU Allocates €3.4 Billion to 77 Projects Advancing Net-Zero Technologies

    October 20, 2026

    Italy’s Growth Outlook for 2026 Is Elevated to 1% by the Bank of Italy

    October 19, 2026

    EU Introduces New Anti-Trafficking Strategy Amid Rising Victim Numbers Exceeding 20,000

    October 17, 2026

    EU Implements New Schengen Alert System to Enhance Counter-Terrorism Efforts

    October 16, 2026

    European Union Allocates €115 Million for New Defence Innovation Fund AGILE

    October 13, 2026

    Britain boosts AI security measures amid government cyber vulnerability assessments

    October 13, 2026
    © 2024 Glasgow Argus | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.